Dow Up1.31% Nasdaq Up2.40%

More On 009420.KS



News & Info


  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


HanAll Biopharma Co., Ltd. (009420.KS)

4,020.00 Up 65.00(1.64%) 12:56AM EDT
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:161.66B
Enterprise Value (Oct 22, 2014)3:163.17B
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2015)1:N/A
PEG Ratio (5 yr expected)1:N/A
Price/Sales (ttm):2.05
Price/Book (mrq):2.67
Enterprise Value/Revenue (ttm)3:2.11
Enterprise Value/EBITDA (ttm)6:-26.52
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 31
Most Recent Quarter (mrq):Jun 30, 2014
Profit Margin (ttm):-22.11%
Operating Margin (ttm):-10.72%
Management Effectiveness
Return on Assets (ttm):-4.80%
Return on Equity (ttm):-24.95%
Income Statement
Revenue (ttm):77.51B
Revenue Per Share (ttm):1,914.67
Qtrly Revenue Growth (yoy):6.50%
Gross Profit (ttm):31.55B
EBITDA (ttm)6:-6.15B
Net Income Avl to Common (ttm):-17.13B
Diluted EPS (ttm):-423.24
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):13.72B
Total Cash Per Share (mrq):341.29
Total Debt (mrq):17.85B
Total Debt/Equity (mrq):30.01
Current Ratio (mrq):1.86
Book Value Per Share (mrq):1,479.08
Cash Flow Statement
Operating Cash Flow (ttm):-5.89B
Levered Free Cash Flow (ttm):-8.19B
View Financials
Income Statement - Balance Sheet - Cash Flow

Trading Information 
Stock Price History
52-Week Change3:-36.31%
S&P500 52-Week Change3:11.16%
52-Week High (Oct 23, 2013)3:6,350.00
52-Week Low (Jun 25, 2014)3:3,555.00
50-Day Moving Average3:4,098.38
200-Day Moving Average3:4,111.71
Share Statistics
Avg Vol (3 month)3:138,976
Avg Vol (10 day)3:184,964
Shares Outstanding5:40.21M
% Held by Insiders1:N/A
% Held by Institutions1:N/A
Shares Short 3:N/A
Short Ratio 3:N/A
Short % of Float 3:N/A
Shares Short (prior month)3:N/A
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:10:1
Last Split Date3:May 3, 2006

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Jun 30, 2014)
ttm = Trailing Twelve Months (as of Jun 30, 2014)
yoy = Year Over Year (as of Jun 30, 2014)
lfy = Last Fiscal Year (as of Dec 31, 2013)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in KRW.